Ursodeoxycholic acid
Top View
- Biliary Bile Acids of Bears, Pandas, and Related Carnivores
- New Therapies Postgrad Med J: First Published As 10.1136/Pgmj.73.856.75 on 1 February 1997
- Ursodiol Use Is Possibly Associated with Lower Incidence of Hepatocellular Carcinoma in Hepatitis C Virus–Associated Liver Cirrhosis
- OCALIVA (Obeticholic Acid)
- Changes in Glutathione Content in Liver Diseases: an Update
- Novel Modulation of Adenylyl Cyclase Type 2 Jason Michael Conley Purdue University
- Obeticholic Acid: First Global Approval
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Effectiveness of Ursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis with Ulcerative Colitis: a Pediatric Case
- Marrakesh Agreement Establishing the World Trade Organization
- Future Medical Treatment of PSC
- Treatment with Milk Thistle Extract (Silybum Marianum
- Obeticholic Acid (Ocaliva®) Policy #: Rx.01.186
- Ocaliva (Obeticholic Acid) Prior Authorization with Quantity Limit
- Retrospective Comparison of 'Cheno' and 'Urso' in the Medical
- Functional Disorders in the Sphincter of Oddi and Possibly Reflux-Associated Diseases in the Hepato-Biliary-Cholecysto-Pancreat
- Downloaded from the Protein Data Bank (PDB ID: 6VSB)
- Primary Biliary Cholangitis (PBC) & Ursodeoxycholic Acid (UDCA)